Results 191 to 200 of about 156,017 (326)

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Changes in neural processing and evaluation of negative facial expressions after administration of an open-label placebo [PDF]

, 2022
Anne Schienle, Isabella Unger, Daniela Schwab   +2 more
openalex   +1 more source

Prescribing Placebos: An Experimental Examination of the Role of Dose, Expectancies, and Adherence in Open-Label Placebo Effects.

Annals of Behavioral Medicine, 2019
Jason El Brihi, R. Horne, Kate Faasse
semanticscholar   +1 more source

Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes in youth with axial juvenile spondyloarthritis (axJSpA) initiating TNF inhibitor (TNFi).
Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss   +8 more
wiley   +1 more source

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial [PDF]

, 2019

core   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

Leland W.K. Chung, Richard M. Silver, Virginia Steen, Daniel E. Furst, Flavia V. Castelino, Marcin A. Trojanowski, Robert Spiera, Robyn T. Domsic, Alicia Rodríguez-Pla, Tamiko R. Katsumoto, Hélène Goulaouic, Hong Wang, Melanie Espinasse, Souheil El‐Chemaly, Rui Wang   +14 more
openalex   +1 more source

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

, 2014
Steen Lindkær-Jensen, Stig Larsen, Kritiya Butthongkomvong, Alexey Manikas, Ekaterina Trishkina, Elena Poddubudkaya, Marina Matrosova, Vichien Srimuninnimit   +7 more
openalex   +2 more sources

Do we need to deceive to achieve within placebo analgesia: How does personality influence open-label placebo and deceptive placebo responding? [PDF]

, 2020
Nathan Disley
openalex  

The Effect of Fast Food Restaurants on Obesity [PDF]

We investigate the health consequences of changes in the supply of fast food using the exact geographical location of fast food restaurants. Specifically, we ask how the supply of fast food affects the obesity rates of 3 million school children and the ...
Currie, Janet, DellaVigna, Stefano, Moretti, Enrico, Pathania, Vikram   +3 more
core   +1 more source